Potentiation of long-acting β(2)-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP

INTRODUCTION: Over 300 million people in the world live with asthma, resulting in 500,000 annual global deaths with future increases expected. It is estimated that around 50–80% of asthma exacerbations are due to viral infections. Currently, a combination of long-acting beta agonists (LABA) for bron...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yechan, Hou, Vincent, Huff, Ryan D., Aguiar, Jennifer A., Revill, Spencer, Tiessen, Nicholas, Cao, Quynh, Miller, Matthew S., Inman, Mark D., Ask, Kjetil, Doxey, Andrew C., Hirota, Jeremy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527633/
https://www.ncbi.nlm.nih.gov/pubmed/34666750
http://dx.doi.org/10.1186/s12931-021-01862-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527633/
https://www.ncbi.nlm.nih.gov/pubmed/34666750
http://dx.doi.org/10.1186/s12931-021-01862-1

Ejemplares similares